BIO-key International, Inc. BKYI
$2.65
-$0.10-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.87% | -46.38% | -66.43% | 19.59% | 36.95% |
| Total Depreciation and Amortization | -31.73% | -26.11% | -21.01% | -5.19% | 7.02% |
| Total Amortization of Deferred Charges | 35.25% | 39.19% | 44.98% | 75.09% | 82.59% |
| Total Other Non-Cash Items | 1,236.78% | 2,355.67% | 2,372.52% | -78.94% | -96.67% |
| Change in Net Operating Assets | 113.64% | 30.07% | -145.31% | 77.91% | -167.77% |
| Cash from Operations | -18.57% | -3.58% | -60.21% | 14.71% | -24.25% |
| Capital Expenditure | 65.90% | 53.16% | 8.40% | 110.79% | -496.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.90% | 53.16% | 8.40% | 110.79% | -496.55% |
| Total Debt Issued | -- | -50.00% | -50.00% | -42.78% | -100.00% |
| Total Debt Repaid | 37.36% | 33.25% | 34.10% | 60.12% | 61.25% |
| Issuance of Common Stock | -45.63% | -45.76% | 248.00% | -39.31% | 35.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.47% | 49.47% | -168.62% | 59.56% | 27.54% |
| Cash from Financing | -23.13% | -47.82% | 144.52% | -30.59% | 30.10% |
| Foreign Exchange rate Adjustments | -193.16% | -133.30% | -3.41% | -114.66% | -0.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.29% | -136.25% | 3,158.27% | -84.02% | 46.09% |